No Data
No Data
Reported Wednesday, Zai Lab Announces AUGTYRO Inclusion For ROS1+ NSCLC In China's Updated National Reimbursement Drug List
Zai Lab's AUGTYRO For ROS1+ NSCLC Added To China's National Reimbursement Drug List
Express News | Zai Lab Announces the Inclusion of Augtyro® (Repotrectinib) for Ros1+ Nsclc and Other Updates in China’s National Reimbursement Drug List
Asian Equities Traded in the US as American Depositary Receipts Edge Higher in Monday Trading
Zai Lab Raises $216 Million Through ADS Offering
Hong Kong stocks fluctuate | Zai Lab (09688) rises over 5% as it cooperates with Pfizer on the new antibacterial drug in mainland China.
zai lab (09688) rose more than 5%, as of the deadline, it increased by 5.26%, closing at 20.8 Hong Kong dollars, with a turnover of 7.8692 million Hong Kong dollars.
No Data
No Data
Methods : and yet it's red!
Stock_Drift OP Methods : Red is making its rounds this morning, I’ll agree with that.
Methods Stock_Drift OP : No this is always red.. 24.5 seems to be strong support though
Stock_Drift OP Methods : Fair enough